Trial Profile
Phase I /IIa trial of interferon alpha kinoid in patients with systemic lupus erythematosus in USA
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 20 Aug 2015
Price :
$35
*
At a glance
- Drugs Interferon alpha kinoid (Primary)
- Indications Systemic lupus erythematosus
- Focus Adverse reactions; Therapeutic Use
- Sponsors Neovacs
- 09 Mar 2015 The title is not official. Trial focus assumed based on the phase.
- 09 Mar 2015 New trial record